DEMERX

DemeRx is a clinical stage pharmaceutical development company advancing drug candidates as therapies for addiction... DemeRx is currently evaluating patient data which demonstrate that a single dose of ibogaine is sufficient to detoxify opioid-dependent persons and diminish drug cravings for extended time periods... DemeRx is evaluating the safety and pharmacokinetics of ibogaine in normal healthy volunteers and in patients with opioid abuse problems.

Also known as: DemeRx IB, DemeRx IB, Inc.

Primary location: Miami United States